Aldesleukin Side Effects
Some side effects of aldesleukin may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to aldesleukin: intravenous powder for solution
Along with its needed effects, aldesleukin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking aldesleukin:More common
- fever or chills
- mental depression
- nausea and vomiting
- shortness of breath
- sores in the mouth and on lips
- tingling of the hands or feet
- unusual decrease in urination
- unusual tiredness or weakness
- weight gain of 5 to 10 pounds or more
- Bloating and stomach pain
- blurred or double vision
- fast or irregular heartbeat
- loss of taste
- rapid breathing
- redness, swelling, and soreness of the tongue
- trouble with speaking
- yellow eyes and skin
- Changes in menstrual periods
- convulsions (seizures)
- muscle aches
- pain or redness at injection site
- sudden inability to move
- swelling in the front of the neck
- swelling of the feet or lower legs
- Black, tarry stools
- blisters on the skin
- blood in the urine
- bloody vomit
- chest pain
- cough or hoarseness
- lower back or side pain
- painful or difficult urination
- pinpoint red spots on the skin
- stomach pain (severe)
- unusual bleeding or bruising
Some side effects of aldesleukin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Dry skin
- loss of appetite
- skin rash or redness with burning or itching, followed by peeling
- unusual feeling of discomfort or illness
- joint pain
- muscle pain
For Healthcare Professionals
Applies to aldesleukin: intravenous powder for injection
Cardiovascular side effects from aldesleukin have been reported. Many of the adverse cardiovascular events from aldesleukin result from a capillary or vascular leak syndrome. Shifting of fluid into the interstitial spaces results in hypotension, tachycardia, and sometimes congestive heart failure, or myocardial infarction. Besides the vascular leak syndrome and hypotension, direct effects on the myocardium have been noted. These effects include hemodynamic changes as well as myocardial injury with creatine phosphokinase (CPK) elevations and myocarditis secondary to lymphocyte infiltration.
Hypotension resulting from aldesleukin-induced capillary leak syndrome should be managed with careful fluid administration and institution of low-dose dopamine infusions.
Respiratory side effects including respiratory distress resulting from fluid weight gain attributed to the vascular leak syndrome has been reported. Other respiratory effects reported include dyspnea, pulmonary congestion with rales and rhonchi, unspecified pulmonary changes with infiltrates on X-ray, increased cough, and rhinitis.
Nervous system side effects including both acute and chronic neurologic and neuropsychiatric findings have been reported during aldesleukin administration. Patients receiving high-dose therapy have been reported to have become agitated, disoriented, and sometimes comatose. These effects have typically resolved upon discontinuation of the drug. Neuropsychiatric effects including a decrease in cognitive function and memory impairment have been reported in patients receiving continuous-infusion aldesleukin therapy.
Renal damage attributed to aldesleukin results from the decrease in vascular resistance. Low-dose dopamine helps maintain adequate renal perfusion during aldesleukin therapy and may decrease the incidence of renal failure.
Renal side effects including oliguria and anuria are the predominant adverse events that have been reported in the majority of patients. Acute kidney failure with an increase in creatinine has been reported in 1% of patients.
Hepatic side effects reported with aldesleukin therapy include bilirubinemia, SGOT increase, and alkaline phosphatase increase and hepatosplenomegaly.
Hematopoietic side effects which have been reported include anemia, thrombocytopenia, and leukopenia. Postmarketing reports have included lymphocytopenia.
Antiemetics and antidiarrheals are helpful in treating the gastrointestinal side effects and H2-antagonists are often given for prophylaxis of gastrointestinal irritation and bleeding. Mucositis requires diligent oral care, including sodium bicarbonate mouthwashes and nystatin.
Gastrointestinal side effects have included nausea, vomiting, diarrhea, and mucositis. Colon dilatation, perforation, and ischemic necrosis have also been reported but are uncommon.
Rashes have been treated with either hydroxyzine or diphenhydramine, which can be continued until resolution of the rash. Nonalcoholic-based creams and ointments as well as aloe vera gels may also be applied to skin conditions. Application may begin as early as 48 hours before treatment. Preparations containing steroids should be avoided.
Dermatologic side effects such as erythema, pruritus, and generalized erythroderma have been reported with aldesleukin therapy. In patients with preexisting dermatologic conditions such as psoriasis, exacerbation of the underlying condition has been reported.
Meperidine may be helpful for the chills and rigors associated with this flu-like syndrome. Scheduled nonsteroidal anti-inflammatory drugs like acetaminophen and indomethacin can substantially relieve the other symptoms.
General side effects including a flu-like syndrome have been reported in patients receiving aldesleukin. Symptoms include fever, chills, rigors, joint pain, myalgias, malaise, and anorexia.
Other side effects including infection have been reported with aldesleukin treatment (which may be due to the initial drop in lymphocyte levels).
Endocrine side effects including hypothyroidism and hyperthyroidism have been reported with aldesleukin therapy.
Metabolic side effects seen with aldesleukin treatment have included acidosis, hypomagnesemia, hypocalcemia, and hyperuricemia.
Immunologic side effects have included the formation of anti-aldesleukin antibodies (up to 74%).
More about aldesleukin
- Other brands: Proleukin
Compare with other treatments for:
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.